Accessibility Menu
 
Co-Diagnostics logo

Co-Diagnostics

(NASDAQ) CODX

Current Price$1.47
Market Cap$5.26M
Since IPO (2017)-99%
5 Year-99%
1 Year-86%
1 Month-36%

Co-Diagnostics Financials at a Glance

Market Cap

$5.26M

Revenue (TTM)

$418.20K

Net Income (TTM)

$46.90M

EPS (TTM)

$-31.01

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$1.47

Volume

87,220

Open

$1.44

Previous Close

$1.46

Daily Range

$1.39 - $1.48

52-Week Range

$1.35 - $46.50

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Co-Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

115

CEO

Dwight Howard Egan

Website

co-dx.com

Headquarters

Salt Lake City, UT 84109, US

CODX Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-75%

Net Income Margin

-112%

Return on Equity

-125%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.26M

Shares Outstanding

3.60M

Volume

87.22K

Short Interest

0.00%

Avg. Volume

2.76M

Financials (TTM)

Gross Profit

$910.98K

Operating Income

$31.49M

EBITDA

$30.18M

Operating Cash Flow

$29.14M

Capital Expenditure

$700.05K

Free Cash Flow

$29.84M

Cash & ST Invst.

$11.88M

Total Debt

$1.24M

Co-Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$59.64K

-60.1%

Gross Profit

$1.19M

-1025.0%

Gross Margin

-19.95%

N/A

Market Cap

$5.26M

N/A

Market Cap/Employee

$39.85K

N/A

Employees

132

N/A

Net Income

$25.75M

-133.4%

EBITDA

$7.39M

+36.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.65M

-61.4%

Accounts Receivable

$190.38K

+43.6%

Inventory

$992.40K

-7.5%

Long Term Debt

$574.30K

-53.6%

Short Term Debt

$662.26K

-27.7%

Return on Assets

-1.90%

N/A

Return on Invested Capital

-1.49%

N/A

Free Cash Flow

$6.33M

+23.8%

Operating Cash Flow

$6.20M

+24.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALURAllurion Technologies Inc.
$0.77-3.75%
TNONTenon Medical, Inc.
$0.82+1.24%
VVOSVivos Therapeutics, Inc.
$1.09-25.85%
SINTSintx Technologies, Inc.
$2.68-2.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$198.35-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$56.43+0.01%
SOFISoFi Technologies
$19.03+0.01%

Questions About CODX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.